# Phase 1 Study to Determine Safety, Blood PK and Lung Penetration

> **NCT01034774** · PHASE1 · COMPLETED · sponsor: **Achaogen, Inc.** · enrollment: 40 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** ACHN-490 Injection
- **DRUG:** Placebo (normal saline)

## Key facts

- **NCT ID:** NCT01034774
- **Lead sponsor:** Achaogen, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-06
- **Final completion:** 2010-07
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2012-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01034774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01034774, "Phase 1 Study to Determine Safety, Blood PK and Lung Penetration". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01034774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*